comprehensive -WSS

comprehensive

author：hotspot 2025-10-02 13:37:35 - browse：1433

Fran van Delft for Galapagos

Seeking to differentiate itself from other makers of CAR-T cancer therapies, Galapagos NV on Wednesday announced it had struck a deal with Blood Centers of America to open up dozens of manufacturing sites for its cell-based medicines around the U.S.

Galapagos said it will rely on the partnership, the financial terms of which were not disclosed, as it moves its CAR-Ts for different cancers into pivotal studies and could also help launch those medicines should they win approval. The Belgian company framed the collaboration as one that could help overcome the limitations that have held back access to existing CAR-T therapies from other companies.

CAR-Ts have proven to be potent treatments for certain cancers, but they are complicated medicines to make. Immune cells have to be removed from a patient, shipped to specialty sites, where they’re engineered with cancer-killing abilities, and then returned to the hospital for infusion back into patients. The process, which can take weeks if not months, has put a crunch on the number of patients companies and hospitals are able to treat.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Eat, drink, but be wary — 4 foods that interact with medications

WSS

Ancient Greek ideas underpin modern concepts of pregnancy

Eat, drink, but be wary — 4 foods that interact with medications

New company forms to vet health AI models, root out weaknesses

Immune cells and nerve overgrowth may explain recurring UTI pain

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

State of the Union pitch: Bigger Medicare drug price negotiations

knowledge

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Medicare details structure of new drug price negotiation program

California Joshua trees severely burned in massive wildfire

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Change Healthcare: What is it, why does its cyberattack matter?

In age of alternative facts, a scholarly course on calling out crap

Medical mystery: When an infection after surgery isn’t what it seems

Wildfire smoke exposes gaps in outdoor worker protections

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Jerome Adams on the need for new antivirals for Covid

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

knowledge

IVF doctors demand details after CooperSurgical lawsuit

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Russian court extends detention of American musician

California Joshua trees severely burned in massive wildfire

Pregnant women don't need prenatal multivitamins, study concludes

Immune cells and nerve overgrowth may explain recurring UTI pain

focus

explore

hotspot

knowledge